Companion Diagnostic Co-Development

We Build. We Validate. We Deliver.

ResearchDx integrates and aligns IVD and pharma development that simplifies, speeds and ensures delivery of your FDA-approved companion diagnostics.

We Are With You Every Step of the Way.

Identify & Finalize Biomarker(s)

Develop & Refine IVD Assay

Validate in Clinical Trials

FDA Regulatory Filing / Approval

GMP Manufacture Final IVD Kit

Companion DX to Market

We Are With You Every Step of the Way.

Identify & Finalize Biomarker(s)

Develop & Refine IVD Assay

Validate in Clinical Trials

FDA Regulatory Filing / Approval

GMP Manufacture Final IVD Kit

Companion DX to Market

Avoid Multi-Partner Outsourcing.

Watch Video

Bridging IVDx Gaps

ResearchDx solves gaps in resources and expertise for pharmaceutical and diagnostics companies.

» Comprehensive Services

Custom Diagnostics

ResearchDx provides independent IVD support services, allowing us to build and tailor to your needs.

» Custom Services

ResearchDx Lab

As a CAP, CLIA, GLP and ISO compliant clinical and molecular laboratory, we offer a broad range of testing services and consulting.

» Laboratory Services

Latest News

Association for Molecular Pathology (AMP)

Irvine, CA — November 7, 2017 — ResearchDx will be at the Association for Molecular Pathology (AMP) in Salt Lake City, Utah, November 16-18, 2017. Please visit us at booth 608 or call us at 866.225.9195 or 949.812.6902 to set up a consultation at the show.

ResearchDx and Menarini Silicon Biosystems Launch DEPArray HER2 for Breast and GEA Cancers

Irvine, CA—October 2, 2017—ResearchDx, the leading biopharma companion diagnostics provider and Menarini Silicon Biosystems, worldwide manufacturer of image-based cell sorting products and services, jointly announce the launch of DEPArray HER2. The fluorescence in situ hybridization (FISH)-based assay has been validated as a clinical research laboratory developed test (LDT) and is performed by PacificDx, a CAP/CLIA certified and […]